• SENSEX 78,009.25
    -70.71 (--0.09%)
  • BANKNIFTY 57,491.10
    -144.15 (--0.25%)
  • ICICI Pru Life
    511.95 706.50(%)
  • HDFC Bank
    729.65 1,020.35(%)
  • Apollo Hospitals
    8,925.00 9,326.80(%)
  • Wework India
    700.00 419.60(%)
  • LG Electronics
    1,736.35 1,736.40(%)
  • Gland Pharma
    3,039.00 3,039.00(%)
  • Bharti Airtel
    2,005.65 2,174.70(%)
  • Leap India
    143.10 143.10(%)
  • Blue Star
    1,497.00 1,450.00(%)
  • Cupid
    288.00 32.76(%)
  • Netweb Technol.
    4,995.00 2,037.65(%)
  • Honasa Consumer
    509.90 509.90(%)
  • Manorama Indust.
    1,867.00 1,867.00(%)
  • Vodafone Idea
    14.17 15.35(%)
  • Technocraft Ven.
    334.60 334.60(%)
  • Bharat Dynamics
    1,420.00 1,655.25(%)
  • Dixon Technolog.
    14,210.00 18,471.50(%)
  • Billionbrains
    194.60 112.02(%)
  • Infosys
    1,159.00 984.00(%)
  • Gujarat Fluoroch
    4,897.00 4,959.45(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Vasundhara Rasayans Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 2723.0
  • ISIN : INE406F01010
182.00 0 (-0.14%)
  • As on 15 Aug 2026 (EOD)

  • Today’s Low

    181.80

  • Today’s High

    188.00

  • Open

    184.00

  • Perv Close

    182.25

  • 52W Low

    100.10

  • 52W High

    220.00

Key Indicators

  • P/E(TTM)

    9.99

  • Mar.Cap (₹Cr.)

    57.84

  • Div & Yield %

    1.10

  • Book Value(₹)

    128.61

  • Debt-Equity Ratio

    -0.14

  • AGM Date

    14-Aug-2026

  • EPS

    18.22

  • P/E Ratio

    9.99

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    57.84

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    3.18

  • BV (₹)

    128.60

  • Sales( ₹ in Cr.)

    35.72

  • NP (in Cr.)

    5.79

  • NP Var(%)

    36.0

  • Div%

    20.0

  • CPS (₹)

    19.60

  • EPS (₹)

    18.20

  • Traded Value (₹ in Lakhs)

    57.84

  • 52 Week High

    220.00

  • 52 Week Low

    100.10

  • Price BSE

    182.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    57.84

  • P/C Ratio

    9.30

  • P/E Ratio

    10.00

  • Price Vs.BV

    18.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 35.72 33.99 37.02 37.94 26.75 22.68
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 35.72 33.99 37.02 37.94 26.75 22.68
Other Income 2.90 2.35 1.94 2.30 1.04 0.99
Stock Adjustments 0.08 0.15 -0.72 0.90 0.21 -0.35
Total Income 38.70 36.49 38.24 41.14 28.00 23.32
EXPENDITURE :            
Raw Materials 15.18 15.63 15.53 19.27 14.14 10.37
Power and Fuel Cost 0.65 0.64 0.55 0.47 0.34 0.57
Employee Cost 3.28 3.27 3.28 2.60 2.27 3.42
Other Manufacturing Expenses 4.30 4.10 4.23 4.14 2.85 1.37
Selling and Administration Expenses 6.29 6.21 6.10 6.79 4.75 3.30
Miscellaneous Expenses 0.27 0.19 0.17 0.02 0.41 0.19
Employee Benefit Expenses 3.28 3.27 3.28 2.60 2.27 3.42
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 29.96 30.03 29.87 33.28 24.75 19.22
Operating Profit 8.74 6.46 8.37 7.86 3.25 4.10
Interest 0.45 0.34 0.21 0.25 0.09 0.09
Gross Profit 8.29 6.12 8.16 7.61 3.16 4.01
Depreciation 0.43 0.36 0.26 0.13 0.12 0.05
Profit Before Tax 7.86 5.76 7.90 7.48 3.04 3.96
Current Tax 2.09 1.52 1.99 1.89 0.87 1.02
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.01 0.00 0.05 0.00 0.00 0.00
Reported Net Profit 5.79 4.25 5.86 5.59 2.17 2.94
Extraordinary Items 0.00 0.00 0.00 0.00 0.27 0.00
Adjusted Net Profit 5.79 4.25 5.86 5.59 1.90 2.94
Adjustment below Net Profit 0.16 0.01 -0.10 0.01 -0.03 0.00
P & L Balance brought forward 32.17 28.55 23.43 18.15 16.48 14.02
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.64 0.64 0.64 0.32 0.48 0.48
P & L Balance carried down 37.48 32.17 28.55 23.43 18.15 16.48
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 20.00 20.00 0.00 0.00 10.00 15.00
Dividend Per Share(Rs) 2.00 2.00 0.00 0.00 1.00 1.50
Earnings Per Share-Unit Curr 18.22 13.36 18.44 17.59 6.84 9.24
Earnings Per Share(Adj)-Unit Curr 18.22 13.36 18.44 17.59 6.84 9.24
Book Value 128.61 111.88 100.49 84.38 67.76 62.52
Book Value(Adj)-Unit Curr 128.61 111.88 100.49 84.38 67.76 62.52

Shareholding Pattern

  • Promoter Group

    61.98%

  • Public Share Holding

    38.02%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 1,969,920 61.98 1,969,920 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,969,920 61.98 1,969,920 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 144,611 4.55 142,711 22
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 29,501 0.93 29,501 52
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 24,415 0.77 1,101 74
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 52,875 1.66 52,875 2
Individuals holding nominal share capital up to Rs. 1 lakh 910,398 28.65 643,198 5,825
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 46,480 1.46 46,480 1
Sub Total 1,208,280 38.02 915,866 5,976
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 3,178,200 100.00 2,885,786 5,977

Company Background

Vasundhara Rasayans LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Vasundhara Rasayans Ltd
  • BSE Code : 2723.0
  • ISIN : INE406F01010

  • Incorporation Year

    1987

  • Registered Office

    Shed No 42 Phase II IDA
    Mallapur, Hyderabad,
    Telangana-500076

  • Telephone

    91-40-23437617/23437623

  • FAX

    91-40-23437627

  • Chairman

  • Managing Director

  • Company Secretary

    SANTOSH KUMAR JHA

  • Auditor

    Mamta Jain & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    CIL Securities Limited
    214 RaghavaRatna Tow,
    Chiragali Lane,Abids
    Mumbai - Hyderabad 500001

Vasundhara Rasayans Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Vasundhara Rasy. 182.00 38.63 35.72 9.99 20.16
Abbott India 27,076.90 7,217.19 6,929.05 35.63 43.78
Astrazeneca Phar 7,753.70 2,304.07 2,275.58 114.28 27.86
Glaxosmi. Pharma 2,689.10 3,932.76 3,790.20 42.96 58.17
Novartis India 1,586.70 398.23 356.27 40.07 16.64
Cipla 1,450.00 20,102.60 18,979.95 38.11 13.88
Bliss GVS Pharma 524.05 773.53 729.81 48.66 12.51
Amrutanjan Healt 494.75 469.50 451.82 26.50 21.89
Fermenta Biotec. 449.40 474.15 450.25 20.98 18.77
Guj. Themis Bio. 349.05 152.47 150.80 78.09 27.21
Ambalal Sarabhai 42.47 19.52 3.94 78.65 6.77